Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: Results at six months
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
EJ Topol, RM Califf, HF Weisman, SG Ellis… - The …, 1994 - ohiostate.elsevierpure.com
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
[引用][C] Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months.
EJ TOPOL - Lancet, 1994 - cir.nii.ac.jp
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for
reduction of clinical restenosis: results at six months. | CiNii Research CiNii 国立情報学研究所 …
reduction of clinical restenosis: results at six months. | CiNii Research CiNii 国立情報学研究所 …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators
EJ Topol, RM Califf, HF Weisman… - Lancet (London …, 1994 - pubmed.ncbi.nlm.nih.gov
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
Randomised trial of coronary intervention with antibody against platelet/IIb/IIIa integrin for...
EJ Topol, RM Califf - The Lancet, 1994 - elibrary.ru
Shows that the current approach of using aspirin during coronary intervention as the sole
anti-platelet strategy is insufficient to stop the platelet response to vascular injury …
anti-platelet strategy is insufficient to stop the platelet response to vascular injury …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.
EJ Topol, RM Califf, HF Weisman, SG Ellis… - Lancet (London …, 1994 - europepmc.org
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
EJ Topol, RM Califf, HF Weisman, SG Ellis, JE Tcheng… - The Lancet, 1994 - thelancet.com
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
[引用][C] Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months
EJ TOPOL, RM CALIFF, K SIGMON… - Lancet (British …, 1994 - pascal-francis.inist.fr
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for
reduction of clinical restenosis : results at six months CNRS Inist Pascal-Francis CNRS …
reduction of clinical restenosis : results at six months CNRS Inist Pascal-Francis CNRS …
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
EJ Topol, RM Califf, HF Weisman, SG Ellis… - The …, 1994 - scholars.northwestern.edu
Restenosis after coronary angioplasty occurs in at least 30% of patients in the first six
months and, as yet, there is no known treatment to decrease this event. We tested a …
months and, as yet, there is no known treatment to decrease this event. We tested a …
[引用][C] Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
EJ Topol, RM Califf, HF Weisman, SG Ellis, JE Tcheng… - The Lancet, 1994 - cir.nii.ac.jp
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for
reduction of clinical restenosis: results at six months | CiNii Research CiNii 国立情報学研究所 …
reduction of clinical restenosis: results at six months | CiNii Research CiNii 国立情報学研究所 …
